ACAD
39.13
+1.06
+2.78%
AEMD
7.73
-0.12
-1.53%
APRI
1.61
-0.08
-4.73%
ARNA
2.75
+0.05
+1.85%
ATEC
0.59
+0.02
+3.51%
CNAT
3.85
-0.12
-3.02%
CRXM
0.34
-0.01
-2.86%
CYTX
0.37
+0.02
+4.73%
DXCM
88.01
-1.36
-1.52%
GNMK
9.51
-0.3
-3.06%
HALO
16.85
-0.69
-3.93%
ILMN
195.45
-2.66
-1.34%
INNV
0.101
-0.009
-8.098%
INO
7.09
-0.14
-1.94%
ISCO
3.58
-0.12
-3.24%
ISIS
51.57
-0.18
-0.35%
LGND
88.94
-3.48
-3.77%
LPTN
0.25
+0.01
+3.52%
MBVX
1.65
-0.04
-2.08%
MEIP
1.91
+0.05
+2.69%
MNOV
3.16
+0.02
+0.64%
MRTX
25.98
-1.86
-6.68%
MSTX
0.47
-0.01
-1.28%
NBIX
48.09
-1.54
-3.10%
NUVA
51.69
-0.46
-0.88%
ONCS
5.81
+0.05
+0.87%
ONVO
2.5
-0.14
-5.30%
OREX
2.75
+0.01
+0.18%
OTIC
21.56
-0.83
-3.71%
QDEL
20.76
-0.69
-3.22%
RCPT
231.96
0.00
0.00%
RGLS
8.45
-0.79
-8.55%
RMD
51.63
-0.28
-0.54%
SCIE
0.014
0.00
0.00%
SPHS
0.84
-0.01
-1.18%
SRNE
12.71
-0.61
-4.58%
TROV
5.94
-0.39
-6.16%
VICL
0.605
+0.004
+0.7327%
VOLC
18
0.00
0.00%
ZGNX
19.63
-0.87
-4.24%
ACAD
39.13
+1.06
+2.78%
AEMD
7.73
-0.12
-1.53%
APRI
1.61
-0.08
-4.73%
ARNA
2.75
+0.05
+1.85%
ATEC
0.59
+0.02
+3.51%
CNAT
3.85
-0.12
-3.02%
CRXM
0.34
-0.01
-2.86%
CYTX
0.37
+0.02
+4.73%
DXCM
88.01
-1.36
-1.52%
GNMK
9.51
-0.3
-3.06%
HALO
16.85
-0.69
-3.93%
ILMN
195.45
-2.66
-1.34%
INNV
0.101
-0.009
-8.098%
INO
7.09
-0.14
-1.94%
ISCO
3.58
-0.12
-3.24%
ISIS
51.57
-0.18
-0.35%
LGND
88.94
-3.48
-3.77%
LPTN
0.25
+0.01
+3.52%
MBVX
1.65
-0.04
-2.08%
MEIP
1.91
+0.05
+2.69%
MNOV
3.16
+0.02
+0.64%
MRTX
25.98
-1.86
-6.68%
MSTX
0.47
-0.01
-1.28%
NBIX
48.09
-1.54
-3.10%
NUVA
51.69
-0.46
-0.88%
ONCS
5.81
+0.05
+0.87%
ONVO
2.5
-0.14
-5.30%
OREX
2.75
+0.01
+0.18%
OTIC
21.56
-0.83
-3.71%
QDEL
20.76
-0.69
-3.22%
RCPT
231.96
0.00
0.00%
RGLS
8.45
-0.79
-8.55%
RMD
51.63
-0.28
-0.54%
SCIE
0.014
0.00
0.00%
SPHS
0.84
-0.01
-1.18%
SRNE
12.71
-0.61
-4.58%
TROV
5.94
-0.39
-6.16%
VICL
0.605
+0.004
+0.7327%
VOLC
18
0.00
0.00%
ZGNX
19.63
-0.87
-4.24%
Home » Bio: Brian Orelli

Bio: Brian Orelli

Somewhere between his graduate thesis at the University of Chicago on BRCA1 and his postdoctoral fellowship in DNA repair at the Ludwig Institute, Brian realized he enjoyed analyzing other people’s data more than running his own experiments. And thus a career in science writing was born. Brian provides freelance articles for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let him write at the intersection of drugs and business.